Title: 
Official Title: To provide funding for programs and activities of the National
            Center for HIV, Viral Hepatitis, STD, and Tuberculosis Prevention of the Centers for
            Disease Control and Prevention, and for other purposes.
Number of Sections: 2
Source: versions - Introduced in House
Media Type: text/xml

================================================================================

Section 1:
1.
            Short title
 This Act may be cited as the HIV Prevention Now Act.

Section 2:
2.
            Funding for National Center for HIV, Viral Hepatitis, STD, and Tuberculosis
                Prevention
            
                (a)
                In general
 There is hereby appropriated for programs and activities of the National Center for HIV, Viral Hepatitis, STD, and Tuberculosis Prevention of the Centers for Disease Control and Prevention $2,165,000,000 for fiscal year 2026.
            
            
                (b)
                Treatment of funds
 Funds made available under subsection (a)—  (1) shall be in addition to other amounts appropriated to the Department of Health and Human Services, including the Centers for Disease Control and Prevention;
                
                
                    (2)
 shall be used exclusively for the purposes specified in subsection (a); and
                
                
                    (3)
 may not be transferred to any entity other than the National Center for HIV, Viral Hepatitis, STD, and Tuberculosis Prevention.


================================================================================

Raw Text:
119 HR 5126 IH: HIV Prevention Now Act
U.S. House of Representatives
2025-09-04
text/xml
EN
Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.



        I
        119th CONGRESS
        1st Session
        H. R. 5126
        IN THE HOUSE OF REPRESENTATIVES
        
            September 4, 2025
            Ms. Waters (for herself, Mr. Garcia of California, Mr. Nadler, Ms.
                    Norton, Mr. Thompson of
                    Mississippi, Mr.
                    Krishnamoorthi, Ms. Garcia of
                    Texas, Ms. Velázquez,
                    Ms. Sewell, Mr. Carson, Mr.
                    Jackson of Illinois, Ms.
                    Titus, Mr. Johnson of
                    Georgia, Mrs. McIver,
                    Mrs. Beatty, Mr. Cleaver, Mr.
                    Cohen, Ms. Wilson of
                    Florida, Ms. Simon,
                    Mr. Thanedar, Mr. Mullin, Mrs.
                    Ramirez, Ms. Barragán,
                    Mrs. Watson Coleman, Ms. Tlaib, Ms. Clarke
                    of New York, and Ms. Williams of
                    Georgia) introduced the following bill; which was referred to the
                    Committee on
                    Appropriations
        
        A BILL
        To provide funding for programs and activities of the National
            Center for HIV, Viral Hepatitis, STD, and Tuberculosis Prevention of the Centers for
            Disease Control and Prevention, and for other purposes.
    
    
        
            1.
            Short title
 This Act may be cited as the HIV Prevention Now Act.
        
        
            2.
            Funding for National Center for HIV, Viral Hepatitis, STD, and Tuberculosis
                Prevention
            
                (a)
                In general
 There is hereby appropriated for programs and activities of the National Center for HIV, Viral Hepatitis, STD, and Tuberculosis Prevention of the Centers for Disease Control and Prevention $2,165,000,000 for fiscal year 2026.
            
            
                (b)
                Treatment of funds
 Funds made available under subsection (a)—  (1) shall be in addition to other amounts appropriated to the Department of Health and Human Services, including the Centers for Disease Control and Prevention;
                
                
                    (2)
 shall be used exclusively for the purposes specified in subsection (a); and
                
                
                    (3)
 may not be transferred to any entity other than the National Center for HIV, Viral Hepatitis, STD, and Tuberculosis Prevention.